301 related articles for article (PubMed ID: 27313150)
1. Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures.
Lonoce C; Salem R; Marusic C; Jutras PV; Scaloni A; Salzano AM; Lucretti S; Steinkellner H; Benvenuto E; Donini M
Biotechnol J; 2016 Sep; 11(9):1209-20. PubMed ID: 27313150
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Secretion of a Glyco-Engineered Anti-CD20 scFv-Fc Antibody in Hairy Root Cultures.
Lonoce C; Marusic C; Morrocchi E; Salzano AM; Scaloni A; Novelli F; Pioli C; Feeney M; Frigerio L; Donini M
Biotechnol J; 2019 Mar; 14(3):e1800081. PubMed ID: 29975457
[TBL] [Abstract][Full Text] [Related]
3. Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation.
Lombardi R; Donini M; Villani ME; Brunetti P; Fujiyama K; Kajiura H; Paul M; Ma JK; Benvenuto E
Transgenic Res; 2012 Oct; 21(5):1005-21. PubMed ID: 22238065
[TBL] [Abstract][Full Text] [Related]
4. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
[TBL] [Abstract][Full Text] [Related]
5. Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production.
Li J; Stoddard TJ; Demorest ZL; Lavoie PO; Luo S; Clasen BM; Cedrone F; Ray EE; Coffman AP; Daulhac A; Yabandith A; Retterath AJ; Mathis L; Voytas DF; D'Aoust MA; Zhang F
Plant Biotechnol J; 2016 Feb; 14(2):533-42. PubMed ID: 26011187
[TBL] [Abstract][Full Text] [Related]
6. High-yield production of a human monoclonal IgG by rhizosecretion in hydroponic tobacco cultures.
Madeira LM; Szeto TH; Henquet M; Raven N; Runions J; Huddleston J; Garrard I; Drake PM; Ma JK
Plant Biotechnol J; 2016 Feb; 14(2):615-24. PubMed ID: 26038982
[TBL] [Abstract][Full Text] [Related]
7. Controlled glycosylation of therapeutic antibodies in plants.
Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
[TBL] [Abstract][Full Text] [Related]
8. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco.
Drake PM; Barbi T; Sexton A; McGowan E; Stadlmann J; Navarre C; Paul MJ; Ma JK
FASEB J; 2009 Oct; 23(10):3581-9. PubMed ID: 19470800
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.
Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L
Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180
[TBL] [Abstract][Full Text] [Related]
10. The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants.
Limkul J; Iizuka S; Sato Y; Misaki R; Ohashi T; Ohashi T; Fujiyama K
Plant Biotechnol J; 2016 Aug; 14(8):1682-94. PubMed ID: 26868756
[TBL] [Abstract][Full Text] [Related]
11. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H
Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab and Pertuzumab Plant Biosimilars: Modification of Asn297-linked Glycan of the mAbs Produced in a Plant with Fucosyltransferase and Xylosyltransferase Gene Knockouts.
Komarova TV; Sheshukova EV; Kosobokova EN; Serebryakova MV; Kosorukov VS; Tashlitsky VN; Dorokhov YL
Biochemistry (Mosc); 2017 Apr; 82(4):510-520. PubMed ID: 28371609
[TBL] [Abstract][Full Text] [Related]
13. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA
Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534
[TBL] [Abstract][Full Text] [Related]
14. Tobacco against Ebola virus disease.
Budzianowski J
Przegl Lek; 2015; 72(10):567-71. PubMed ID: 26946569
[TBL] [Abstract][Full Text] [Related]
15. N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions.
Marusic C; Pioli C; Stelter S; Novelli F; Lonoce C; Morrocchi E; Benvenuto E; Salzano AM; Scaloni A; Donini M
Biotechnol Bioeng; 2018 Mar; 115(3):565-576. PubMed ID: 29178403
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
[TBL] [Abstract][Full Text] [Related]
17. Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
Tsekoa TL; Lotter-Stark T; Buthelezi S; Chakauya E; Stoychev SH; Sabeta C; Shumba W; Phahladira B; Hume S; Morton J; Rupprecht CE; Steinkellner H; Pauly M; Zeitlin L; Whaley K; Chikwamba R
PLoS One; 2016; 11(7):e0159313. PubMed ID: 27427976
[TBL] [Abstract][Full Text] [Related]
18. Biologically active recombinant human erythropoietin expressed in hairy root cultures and regenerated plantlets of Nicotiana tabacum L.
Gurusamy PD; Schäfer H; Ramamoorthy S; Wink M
PLoS One; 2017; 12(8):e0182367. PubMed ID: 28800637
[TBL] [Abstract][Full Text] [Related]
19. OBTAINING OF THE TRANSGENIC HELIANTHUS TUBEROSUS L. PLANTS, CALLUS AND "HAIRY" ROOT CULTURES ABLE TO EXPRESS THE RECOMBINANT HUMAN INTERFERON ALPHA-2b GENE.
Maistrenko OM; Luchakivska YS; Zholobak NM; Spivak MY; Kuchuk MV
Tsitol Genet; 2015; 49(5):38-44. PubMed ID: 26638495
[TBL] [Abstract][Full Text] [Related]
20. Transient Recombinant Protein Production in Glycoengineered
Sukenik SC; Karuppanan K; Li Q; Lebrilla CB; Nandi S; McDonald KA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
